|
HS Code |
941094 |
| Product Name | Boc-Gln-ONp |
| Full Name | Nα-tert-Butyloxycarbonyl-L-glutamine 4-nitrophenyl ester |
| Molecular Formula | C15H19N3O7 |
| Cas Number | 73360-50-4 |
| Appearance | White to off-white powder |
| Solubility | Soluble in DMF, DMSO, and slightly soluble in methanol |
| Storage Temperature | 2-8°C, protect from light |
| Purity | Typically ≥ 98% |
| Application | Peptide synthesis reagent |
| Functional Groups | Boc (tert-butoxycarbonyl), ONp (4-nitrophenyl ester), amide |
| Smiles | CC(C)(C)OC(=O)N[C@@H](CCC(=O)N[O])C(=O)OC1=CC=C(C=C1)[N+](=O)[O-] |
As an accredited Boc-Gln-ONp factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Boc-Gln-ONp is supplied in a 1-gram amber glass vial with a tamper-evident cap and clear labeling for safe handling. |
| Shipping | Boc-Gln-ONp is typically shipped in a tightly sealed, chemical-resistant container under ambient or cool conditions to prevent moisture and contamination. The package includes proper labeling and documentation, aligning with international regulations for non-hazardous laboratory chemicals. Expedited shipping is recommended to maintain product integrity and ensure timely delivery. |
| Storage | Boc-Gln-ONp should be stored in a tightly sealed container, protected from light and moisture. Keep it at 2-8°C (refrigerated) and in a well-ventilated area. Avoid exposure to heat, acids, or bases, as the compound may decompose. Handle under an inert atmosphere if possible, and store away from incompatible materials to maintain stability and purity. |
Applications of Boc-Gln-ONp in Industrial ManufacturingBoc-Gln-ONp serves as a reliable protected amino acid derivative widely implemented throughout the peptide synthesis value chain, supporting the production of specialized pharmaceuticals, diagnostics, and biotechnological intermediates. Our manufacturing approach ensures strict compliance with batch-to-batch consistency, traceable quality control, and conformance to end-use regulatory requirements worldwide. The following sections demonstrate key applied scenarios for Boc-Gln-ONp in downstream industrial sectors, highlighting standards, integration points, formulation ratios, and end product types our partners actively manufacture using this material. 1. Peptide API Intermediate ProductionPeptide manufacturers consistently select this compound as a glutamine building block protected by tert-butyloxycarbonyl. Its rapid reactivity and reliable cleavage characteristics streamline large-scale solid-phase or solution-phase synthesis workflows, particularly during elongation cycles for complex therapeutic peptide APIs. Clients value the minimized racemization risk and compatibility with existing coupling procedures, enabling higher yields in regulated API environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Diagnostic Peptide SynthesisManufacturers of peptide antigens and controls for IVD (in vitro diagnostic) kits utilize this material for sequence-specific incorporation of glutamine residues during automated and manual peptide syntheses, allowing strict fidelity to epitope mapping requirements. Rapid cleavage and negligible side reactions make it attractive where analytic reproducibility and certificate-of-analysis traceability must be upheld for clinical use diagnostics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Custom Peptide Manufacturing for Research ReagentsCustom peptide producers for biotechnology and academic research sectors use Boc-Gln-ONp in scalable batch modes to synthesize research-grade peptides required for structure-activity relationship studies, epigenetics research, and receptor binding investigations. Its robust shelf life and high purity minimize batch rework, crucial for R&D demands where custom sequences are rapidly prototyped and delivered under short timelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Biotechnological Enzyme Substrate SynthesisIn advanced biocatalysis and enzymology applications, specialty enzyme substrate manufacturers incorporate Boc-Gln-ONp to synthesize glutamine-containing chromogenic or fluorogenic peptide substrates. Its well-characterized leaving group reactivity supports the efficient generation of high-purity substrates for quality assurance and kinetic studies in enzyme assay development. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Pharmaceutical Peptide Impurity Reference Standard ManufacturingPharmaceutical quality control labs and external reference standard suppliers use this material to synthesize specific peptide impurities by sequence-directed incorporation of a protected glutamine. Controlled use during impurity preparation allows accurate mimicry of product-related impurities encountered in peptide API production, enabling validated impurity quantification during batch release and stability studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Boc-Gln-ONp prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our facility, our chemists gather around the reactors every morning, sleeves rolled, ready to push boundaries and do it right. Boc-Gln-ONp has a way of turning expectations on their head. There’s always a joke in the lab that you can tell a lot about a manufacturer’s standards by the quality of their protected amino acid derivatives, and we take pride in setting that bar high. Each batch shares a story of hands-on experience, and for us, this product shows why even subtle differences in synthesis tools matter.
Boc-Gln-ONp, or N-tert-Butoxycarbonyl-L-glutamine p-nitrophenyl ester, steps confidently into the gap where reliable coupling and efficient peptide synthesis meet. Chemists have long appreciated the value of clean reactions and reproducible yields, and Boc-Gln-ONp delivers through consistently high purity and robust performance at the bench. Day in and day out, we watch users shave hours off workflows that stall with more temperamental esters or ill-prepared derivatives.
Our lab teams make Boc-Gln-ONp as a free-flowing, slightly yellow powder. Its p-nitrophenyl group doesn’t just mark it for easy monitoring—there’s a concrete fatigue that comes from struggling with incomplete activation in solid-phase peptide synthesis, so a derivative able to turn over quickly with little side product translates to real savings and fewer headaches. We know synthesis can get noisy, as competing reactions and unforeseen by-products add stress. Every time Boc-Gln-ONp meets an amine, our staff still admire the clarity of the process: activation, coupling, done.
Out in the field, not all Boc-Gln-ONp is created with the same intentions. We manufacture to strict controls, holding our process to a higher standard than what can slip through in bulk commodity batches. Customers have often sent us samples from other sources for comparison. You can see the difference—off-color powders, broad melting ranges, inconsistent assay data. Some may cut corners to chase lower costs, sacrificing purity for yield. Our team doesn’t accept shortcuts. The analytical data for our Boc-Gln-ONp batches, from HPLC and NMR to IR and Karl Fischer titration, reflect what we demand for our own use.
Lot-to-lot reliability isn’t just a talking point. Early in our company’s story, a pharmaceutical partner depended on our batch for a pilot-scale multi-step synthesis. When they tried a cheaper alternative, inconsistent reactivity and unforeseen impurities forced them to spend weeks troubleshooting. We stepped in with a batch drawn from our standard model—no special adjustment needed. Their problem resolved itself, and their faith in our process has never wavered since.
Glutamine’s side-chain amide group and the N-protecting Boc group both play critical roles, but it’s the p-nitrophenyl ester that responds so well to nucleophilic attack, leading to the clean formation of peptide bonds. Our chemists listen closely when contract synthesis teams highlight bottlenecks. Boc-Gln-ONp bridges the performance gap that emerges with less reactive esters, so it moves quickly in solid and solution-phase applications. We designed our process to minimize water content and avoid decomposition, because we know even trace hydrolysis during storage can compromise a sensitive sequence assembly.
Clients come looking for solutions when they want both flexibility and precision. Boc-Gln-ONp makes life easier—solid-phase protocols that grind to a halt elsewhere turn into a seamless flow, which means less downtime and more reliable delivery. Peptide segments built with lower-grade intermediates can end up as puzzle pieces that don’t quite fit, leaving teams frustrated over missed yields and ghost peaks. After using a clean batch of our product, the difference is hard to ignore: clear bands, crisp traces, predictable assembly order.
Many peptide facilities debate the merits of alternative protected glutamine derivatives—N-acylation, other active esters, and different protecting groups. Some chemists opt for Boc-Gln-OSu, others for Fmoc-Gln-ONp or OBt-activated derivatives, depending on technical demands. The knock against the ONp ester from some quarters focuses on cost, but those critics often overlook what hard-won robustness costs to deliver.
We believe it’s all about downstream results. In knockdown trials, less pure starting material almost always warns of problems later: capped yield, poor purity, or unexpected adducts. An unstable product that hydrolyzes too quickly fails in automation, where operators can’t hover over each run. Our experience shows that careful control of esterification, purification, and final drying protects shelf life and preserves reactivity. Process engineers praise the ease with which Boc-Gln-ONp adapts to automated synthesizers, particularly in protocols that avoid repeated capping and recapping steps.
Active esters based on OBt or OSu come with their own hazards and quirks—hydrolytic sensitivity, hazardous byproducts, disposal challenges, or licensing tangles. Boc-Gln-ONp, on the other hand, works cleanly and with few complications, especially given the straightforward ways labs can monitor coupling efficiency through its optical properties. We get calls from contract manufacturers who tried to economize by buying lower-cost esters, only to lose weeks validating processes and purifying crude peptides. Bottlenecks move from the synthetic bench to the purification suite. We’ve learned that one thorough purification up front saves countless hours cleaning up later.
Even as new activation chemistries hit the market, the demands keep circling back to what gives predictable, reproducible results. Boc-Gln-ONp keeps proving itself in everything from simple combinatorial libraries to clinical-stage active pharmaceutical ingredients.
Every major synthesis is traceable and we maintain full batch records, integrating regular stability trials and contamination analysis. We’ve had auditors walk our floor and cite our practices as the model for both mutagen control and nitrosamine risk management, especially in high-purity amino acid derivatives. Because pharmaceutical development tolerates no surprises, our facility builds quality into the entire supply chain to satisfy regulators and customers alike.
Sterility, peptide mapping, and impurity profiling are routine for us. Each release comes with a full certificate detailing not just assay values, but also exact methods. We follow up with periodic revalidation to capture any process drift. Our partners depend on tight upstream control, since any lapse could echo through to high-value products. From the beginning, we leaned into transparent reporting and tight internal controls, fostering trust instead of hiding behind vague claims or limited disclosure.
Early in our journey, we grappled with moisture ingress during packaging. Single-digit increases in water content translated to visible reaction sluggishness. Workstations slowed, and feedback poured in. Redesigning the drying and filling suite took time and effort, but now every pack leaves us with water content well below the stated limit. We’re not complacent—by actively monitoring real feedback from synthetic chemists, we spot trends before they snowball into bigger problems.
One lesson stands out above all: Treat each batch as if it will build a critical link in a life-saving medicine, because often it does. Every protocol and tweak in manufacturing arises from hands-on lessons, not blind adherence to textbook theory. The practical experience from working hand in glove with our customers shapes every lot. As we continue to scale up, our senior chemists spend as much time at customer sites as in our own process rooms, absorbing what’s new in the field and bringing those lessons home. That cross-pollination tightens our approach and translates to tangible benefits in the bottle.
Supply chain hiccups teach more than any textbook. Our team manages everything from vacuum-sealed bottles to container loads, ensuring Boc-Gln-ONp withstands transit shocks, humidity swings, and customs delays. There’s an art to limiting exposure—small tears or leaky bottles harm reactivity and frustrate everyone down the line. Our logistics arm uses sealed drums and active-monitoring moisture cards. We never accept half-measures, because anyone who’s lost a shipment to clumsy handling knows how that can derail development schedules.
We also address risk at the source—maintaining an audit trail through every movement, so stranded material can be traced and replaced rapidly. The time and resource cost of requalification isn’t lost on us. Clients who once switched to alternate products often return, favoring a system where the manufacturer stands firmly behind every lot shipped, solving problems quickly if they arise.
Some of our value is technical; more is cultural. We put as much energy into supporting our users as into the manufacture itself. Protocol sharing, troubleshooting, and post-run analysis happen as part of our routine, not as an afterthought. If a customer encounters low coupling efficiency or unexpected by-products, we walk through their process with them, instead of pointing to others or hiding behind disclaimers.
We’ve found that end-to-end consultation lets us adapt both batch and delivery profile. Project-specific customization is not a marketing tag-line; it’s a reality we see reflected in returning customers year after year. Our people genuinely care about the journey from raw material to finished product, whether that means a single peptide in research or a thousand vials bound for clinical trials.
Modern chemistry must reconcile efficiency with sustainability. Our process optimization reduces solvent use and hazardous by-products, protecting both operator safety and the environment. We regularly invest in closed-loop systems and solvent recycling. These practices aren’t just regulatory obligations—they make good sense. Whether it’s managing disposal of nitrophenyl waste or minimizing residual solvents, we meet increasing standards head on, improving each campaign and learning from every cycle.
We stay close to the science, always watching for signal shifts or new best practices in amino acid activation. Adaptive manufacturing benefits everyone, making high-value molecules affordable and accessible. We work to guarantee that even those on the frontiers of research have access to reliable, uncompromised Boc-Gln-ONp.
Every experienced peptide chemist can recount times spent troubleshooting why a coupling step failed. Missed targets, ghost peaks, or unclean HPLC traces all leave lasting memories. These aren’t abstract problems. Lost projects, wasted budgets, and delayed launches cost people their momentum and, in some cases, the confidence of their backers. The tool you pick at the outset—especially for sensitive intermediates—can decide the whole project’s fate.
By controlling every step from starting material through to packed product, we work to remove the drama from high-stakes synthesis. Research moves fast, but reliable intermediates let innovation keep pace without running off the rails. Whether the goal lies in high-throughput discovery, specialty diagnostics, or life-saving therapies, Boc-Gln-ONp anchors those ambitions with batch after batch of proven results.
Tomorrow’s science sets ever taller demands: tighter impurity thresholds, higher purity, faster throughput, new regulatory vigilance. We believe in continuous upgrade—of our equipment, controls, and know-how. Customers don’t just buy Boc-Gln-ONp from us, they inherit decades of learning distilled into every step. We serve as both sounding board and problem-solver, responding not just to what’s required today, but anticipating what’s coming next year.
With every batch of Boc-Gln-ONp moving through our lines, we carry the trust of researchers and manufacturers alike. Each success story in labs around the world affirms the value of expertise, hands-on problem-solving, and honest commitment as much as any analytical certificate. We move forward with the same dedication that started it all: keep the chemistry clean, own every challenge, and deliver more than a simple product in a bottle.